Merck · 5 hours ago
2026 Future Talent Program - Assoc. Spclst, Quality Assurance - Rotational Program
Merck is a global leader in pharmaceuticals dedicated to quality assurance in vaccine manufacturing. They are seeking an Associate Specialist for their Quality Line Oversight Program, which provides hands-on experience in pharmaceutical quality assurance through a rotational program at their West Point, PA site.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Quality checks of finished product including visual inspection of vials, syringes and packages
Verification of appropriate line clearance between batches to prevent product mix-ups
GMP document / batch record review
Rotational support of Quality Assurance, Quality Operations, and Environmental Monitoring providing a foundational understanding of vaccine Quality oversight and production
Continuous improvement projects by participating in problem solving and partnering with Operations, Technology, and/or other Quality groups in areas such as safety, quality, and efficiency
Qualification
Required
Bachelor's Degree in Engineering or Sciences
Willing to work alternate shifts and weekends
Ability to focus on and obtain results
Good verbal and written communication skills
Ability to effectively collaborate within and across an integrated manufacturing team
Ability to enact conflict resolution
Ability to effectively respond to change
Excellent analytical and organizational skills
High personal integrity, credibility and energy
Flexibility to perform related tasks to support the business
Computer literacy in MS Office, Word, Outlook, Excel
Preferred
0-2 years working experience in cGMP pharmaceutical environment
Experience using Lean/Six Sigma tools
Benefits
Medical
Dental
Vision healthcare
Other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Company data provided by crunchbase